10 results match your criteria: "Endo-ERN Center for Rare Endocrine Conditions[Affiliation]"

Clinical course of COVID-19 in children with Adrenal Insufficiency: Results from National Data.

J Clin Endocrinol Metab

February 2025

Unit of Pediatric Endocrinology, Department of Medical and Translational Sciences, University of Naples Federico II, Endo-ERN Center for Rare Endocrine Conditions, Italy.

Context: There has been concern about a potential increase in the incidence or severity of Coronavirus Disease 2019 (COVID-19) in individuals with adrenal insufficiency (AI). Data on the course of SARS-CoV-2 infection in AI children are lacking.

Objective: Evaluate whether children with AI are more susceptible to the infection or are at risk of severe COVID-19.

View Article and Find Full Text PDF

Glucocorticoid treatment and adrenal suppression in children: current view and open issues.

J Endocrinol Invest

January 2025

Pediatric Endocrinology Unit, Department of Translational Medical Sciences, University of Naples Federico II, Endo-ERN Center for Rare Endocrine Conditions, Naples, Italy.

Article Synopsis
  • Glucocorticoids (GCs) are widely used in treating various pediatric conditions, but long-term use can lead to adrenal insufficiency (GI-AI), which is often overlooked, especially with non-systemic formulations.
  • The review analyzes the impact of chronic GC treatments on the hypothalamic-pituitary-adrenal (HPA) axis and highlights the importance of carefully tapering off GCs to prevent life-threatening conditions like adrenal crisis (AC).
  • The findings stress the need for better understanding and management strategies for GI-AI in children, including monitoring cortisol levels and adjusting treatment to minimize risks associated with steroid withdrawal.
View Article and Find Full Text PDF

Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia.

N Engl J Med

August 2024

From the Departments of Pharmacology and Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical School, and the Endocrinology and Metabolism Section, Medicine Service, Lieutenant Colonel Charles S. Kettles Veterans Affairs Medical Center - both in Ann

Background: Adrenal insufficiency in patients with classic 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH) is treated with glucocorticoid replacement therapy. Control of adrenal-derived androgen excess usually requires supraphysiologic glucocorticoid dosing, which predisposes patients to glucocorticoid-related complications. Crinecerfont, an oral corticotropin-releasing factor type 1 receptor antagonist, lowered androstenedione levels in phase 2 trials involving patients with CAH.

View Article and Find Full Text PDF

Purpose: To investigate the incidence of nephrolithiasis in a cohort of children with congenital adrenal hyperplasia (CAH), and to study if there is an association with the metabolic control of the disease.

Methods: This study was designed as a multicenter 1 year-prospective study involving 52 subjects (35 males) with confirmed molecular diagnosis of CAH due to 21-hydroxylase deficiency (21-OHD). Each patient was evaluated at three different time-points: T0, T1 (+6 months of follow-up), T2 (+12 months of follow up).

View Article and Find Full Text PDF

Importance: Testicular adrenal rest tumors (TARTs), often found in male patients with congenital adrenal hyperplasia (CAH), are benign lesions causing testicular damage and infertility. We hypothesize that chronically elevated adrenocorticotropic hormone exposure during early life may promote TART development.

Objective: This study aimed to examine the association between commencing adequate glucocorticoid treatment early after birth and TART development.

View Article and Find Full Text PDF

Background: Despite the optimization of replacement therapy, adrenal crises still represent life-threatening emergencies in many children with adrenal insufficiency.

Objective: We summarized current standards of clinical practice for adrenal crisis and investigated the prevalence of suspected/incipient adrenal crisis, in relation to different treatment modalities, in a group of children with adrenal insufficiency.

Results: Fifty-one children were investigated.

View Article and Find Full Text PDF

Purpose: To study the current practice for assessing comorbidity in adults with 21-hydroxylase CAH and to assess the prevalence of comorbidity in these adults.

Methods: A structured questionnaire was sent to 46 expert centres managing adults with CAH. Information collected included current therapy and surveillance practice with a particular focus on osteoporosis/osteopaenia, hyperlipidaemia, type 2 diabetes/hyperinsulinaemia, hypertension, CV disease, obesity.

View Article and Find Full Text PDF

Background: The link between the effects of recombinant human growth hormone (rhGH) therapy in patients with growth hormone deficiency (GHD) and Chiari malformation type I (CM-1) is controversial.

Summary: We report the case of a patient with an unusual association of GHD due to ectopic posterior pituitary and CM-1. Our patient developed a headache and worsening of CM-1 after the initiation of rhGH therapy.

View Article and Find Full Text PDF

Context: Nationwide data on children diagnosed with craniopharyngioma (CP) are not available in Italy.

Objective: This work aimed to identify patients' characteristics, type of surgical approach, complications and recurrences, number of pituitary deficits, and number of patients starting growth hormone (GH) treatment.

Methods: A retrospective multicenter collection took place of 145 patients aged 0 to 18 years who underwent surgery for CP between 2000 and 2018, and followed up in 17 Italian centers of pediatric endocrinology.

View Article and Find Full Text PDF

Primary Adrenal Insufficiency in Childhood: Data From a Large Nationwide Cohort.

J Clin Endocrinol Metab

March 2021

Pediatric Endocrinology Unit, Department of Translational Medical Sciences, University of Naples Federico II, Endo-ERN Center for Rare Endocrine Conditions, Naples, Italy.

Context: Primary adrenal insufficiency (PAI) is a rare and potentially life-threatening condition that is poorly characterized in children.

Objective: To describe causes, presentation, auxological outcome, frequency of adrenal crisis and mortality of a large cohort of children with PAI.

Patients And Methods: Data from 803 patients from 8 centers of Pediatric Endocrinology were retrospectively collected.

View Article and Find Full Text PDF